English

TheraBiogen, Inc.

EDGAR

Quarterly report (10-Q) · filed 2012-07-23

32 filing records in this dataset, filed from 2008-02-20 to 2012-07-23. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

205 thousand USD

2011-08-31 · USD

Exact inputs and evidence

Revenue: 204910 USD Source

Operating margin

-266.7%

2011-08-31 · %

Exact inputs and evidence

Operating Income: -546499 USD Source
Revenue: 204910 USD Source

Operating cash flow

-223 thousand USD

2011-08-31 · USD

Exact inputs and evidence

Operating Cash Flow: -392803 USD Source
Operating Cash Flow: -169350 USD Source

Cash and cash equivalents: 19.7 thousand USD 2011-08-31 Source
Exact value

19658 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

675 thousand USD

2010-09-01 – 2011-08-31

Exact inputs and evidence

Revenue: 278512 USD · 2010-09-01 – 2010-11-30 Source
Revenue: 466317 USD · 2010-03-01 – 2011-02-28 Source
Revenue: 278512 USD · 2010-03-01 – 2010-11-30 Source
Revenue: 4213 USD · 2011-03-01 – 2011-05-31 Source
Revenue: 204910 USD · 2011-06-01 – 2011-08-31 Source

Net income

-15.7 million USD

2010-09-01 – 2011-08-31

Exact inputs and evidence

Net income: -644119 USD · 2010-09-01 – 2010-11-30 Source
Net income: -4093379 USD · 2010-03-01 – 2011-02-28 Source
Net income: -3145513 USD · 2010-03-01 – 2010-11-30 Source
Net income: -13392041 USD · 2011-03-01 – 2011-05-31 Source
Net income: -670957 USD · 2011-06-01 – 2011-08-31 Source

Operating cash flow

-1.02 million USD

2010-09-01 – 2011-08-31

Exact inputs and evidence

Operating cash flow: -882047 USD · 2010-03-01 – 2010-11-30 Source
Operating cash flow: -700222 USD · 2010-03-01 – 2010-08-31 Source
Operating cash flow: -1331402 USD · 2010-03-01 – 2011-02-28 Source
Operating cash flow: -882047 USD · 2010-03-01 – 2010-11-30 Source
Operating cash flow: -169350 USD · 2011-03-01 – 2011-05-31 Source
Operating cash flow: -392803 USD · 2011-03-01 – 2011-08-31 Source
Operating cash flow: -169350 USD · 2011-03-01 – 2011-05-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-07-23.

Financial data available through: 2011-02-28.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2011-02-28
Operating income: 2 of 11 periods available· newest 2011-02-28
Net income: 5 of 11 periods available· newest 2011-02-28
Operating cash flow: 5 of 11 periods available· newest 2011-02-28
capital expenditure: No compatible figures in this window
Total assets: 2 of 11 periods available· newest 2011-02-28
Total liabilities: 2 of 11 periods available· newest 2011-02-28
Current assets: 2 of 11 periods available· newest 2011-02-28
Current liabilities: 2 of 11 periods available· newest 2011-02-28
Cash and cash equivalents: 2 of 11 periods available· newest 2011-02-28
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+USD 466,317

Prior period

USD 0

2009-03-01 – 2010-02-28
Current period

USD 466,317

2010-03-01 – 2011-02-28

Exact inputs and evidence

466317 − 0 = 466317 USD

0 USD · 2009-03-01 – 2010-02-28
Inspect prior input Prior source
466317 USD · 2010-03-01 – 2011-02-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · TheraBiogen, Inc. · 2011-02-28 TheraBiogen, Inc. (edgar:1405286) Year-over-year change in Revenue: 466317 USD Concept: fundies:Revenue Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 466317 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#4301 Input fundies:Revenue: 0 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#4301
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3.15 million

Prior period

−USD 945,641

2009-03-01 – 2010-02-28
Current period

−USD 4.09 million

2010-03-01 – 2011-02-28

Exact inputs and evidence

-4093379 − -945641 = -3147738 USD

-945641 USD · 2009-03-01 – 2010-02-28
Inspect prior input Prior source
-4093379 USD · 2010-03-01 – 2011-02-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · TheraBiogen, Inc. · 2011-02-28 TheraBiogen, Inc. (edgar:1405286) Year-over-year change in Net income: -3147738 USD Concept: fundies:NetIncome Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -4093379 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5033 Input fundies:NetIncome: -945641 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5033
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 733,668

Prior period

−USD 597,734

2009-03-01 – 2010-02-28
Current period

−USD 1.33 million

2010-03-01 – 2011-02-28

Exact inputs and evidence

-1331402 − -597734 = -733668 USD

-597734 USD · 2009-03-01 – 2010-02-28
Inspect prior input Prior source
-1331402 USD · 2010-03-01 – 2011-02-28
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · TheraBiogen, Inc. · 2011-02-28 TheraBiogen, Inc. (edgar:1405286) Year-over-year change in Operating cash flow: -733668 USD Concept: fundies:OperatingCashFlow Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1331402 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5185 Input fundies:OperatingCashFlow: -597734 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5185
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2010-03-01 – 2011-02-28

Revenue USD 466,317 100% of revenue
Operating costs Derived USD 4.16 million 893% of revenue
Operating income −USD 3.7 million −793% of revenue
Tax, interest and other Derived USD 396,276 85% of revenue
Net income −USD 4.09 million −878% of revenue

Cash

Operating cash flow −USD 1.33 million −286% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Not shown: operating income or net income is not reported.
2011 Operating loss: operating costs were 893% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2009-03-01 – 2010-02-28	0	883628 Derived	-883628	62013 Derived	-945641	Unavailable	Source 2009-03-01 – 2010-02-28: 0 USD Inspect Revenue Open source 2009-03-01 – 2010-02-28: -883628 USD Inspect Operating Income Open source 2009-03-01 – 2010-02-28: -945641 USD Inspect Net Income Open source 2009-03-01 – 2010-02-28: -597734 USD Inspect Operating Cash Flow Open source
2011 2010-03-01 – 2011-02-28	466317	4163420 Derived	-3697103	396276 Derived	-4093379	Unavailable	Source 2010-03-01 – 2011-02-28: 466317 USD Inspect Revenue Open source 2010-03-01 – 2011-02-28: -3697103 USD Inspect Operating Income Open source 2010-03-01 – 2011-02-28: -4093379 USD Inspect Net Income Open source 2010-03-01 – 2011-02-28: -1331402 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 466.3K 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-02-28	Revenue	0	Revenue: 0 Open source
20112011-02-28	Revenue	466317	Revenue: 466317 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Year over year	No prior comparable period	Revenue: 0 Open source
20112011-02-28	Year over year	No prior comparable period	Revenue: 466317 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -792.8% 2011

Net margin -877.8% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Operating margin	Not reported	Operating Income: -883628 Open source Revenue: 0 Open source
20112011-02-28	Operating margin	-792.8%	Operating Income: -3697103 Open source Revenue: 466317 Open source
20102010-02-28	Net margin	Not reported	Net Income: -945641 Open source Revenue: 0 Open source
20112011-02-28	Net margin	-877.8%	Net Income: -4093379 Open source Revenue: 466317 Open source
20102010-02-28	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -597734 Open source
20112011-02-28	Free cash flow margin	Not reported	Revenue: 466317 Open source Operating Cash Flow: -1331402 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.3M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-02-28	Operating cash flow	-597734	Operating Cash Flow: -597734 Open source
20112011-02-28	Operating cash flow	-1331402	Operating Cash Flow: -1331402 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-02-28	Free cash flow	Unavailable	Operating Cash Flow: -597734 Open source
20112011-02-28	Free cash flow	Unavailable	Operating Cash Flow: -1331402 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

61.2% 2011

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Liabilities / assets	34.8%	Total Liabilities: 836587 Open source Total Assets: 2403434 Open source
20112011-02-28	Liabilities / assets	61.2%	Total Liabilities: 1608024 Open source Total Assets: 2626715 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.24× 2011

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20102010-02-28	Current assets / current liabilities	0.06×	Current Assets: 28695 Open source Current Liabilities: 462587 Open source
20112011-02-28	Current assets / current liabilities	0.24×	Current Assets: 352133 Open source Current Liabilities: 1472024 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-03-01 – 2007-02-28	−USD 17,912 Exact value Exact value: -17912 USD 2006-03-01 – 2007-02-28: -17912 USD Inspect Net Income Open source Share or cite Citation for Net Income · TheraBiogen, Inc. · 2007-02-28 TheraBiogen, Inc. (edgar:1405286) Net Income: -17912 USD Concept: fundies:NetIncome Period: 2006-03-01 to 2007-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3ANetIncome&period=2007-02-28&surface=latest&period_type=duration&start=2006-03-01&unit=USD&dimensions= Input fundies:NetIncome: -17912 USD (2006-03-01 to 2007-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001108078-08-000035.txt#5132 The citation records this snapshot. The page link may show a newer release later.	−USD 5,662 Exact value Exact value: -5662 USD 2006-03-01 – 2007-02-28: -5662 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TheraBiogen, Inc. · 2007-02-28 TheraBiogen, Inc. (edgar:1405286) Operating Cash Flow: -5662 USD Concept: fundies:OperatingCashFlow Period: 2006-03-01 to 2007-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3AOperatingCashFlow&period=2007-02-28&surface=latest&period_type=duration&start=2006-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5662 USD (2006-03-01 to 2007-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001108078-08-000035.txt#5317 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-03-01 – 2008-02-29	−USD 52,206 Exact value Exact value: -52206 USD 2007-03-01 – 2008-02-29: -52206 USD Inspect Net Income Open source Share or cite Citation for Net Income · TheraBiogen, Inc. · 2008-02-29 TheraBiogen, Inc. (edgar:1405286) Net Income: -52206 USD Concept: fundies:NetIncome Period: 2007-03-01 to 2008-02-29 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3ANetIncome&period=2008-02-29&surface=latest&period_type=duration&start=2007-03-01&unit=USD&dimensions= Input fundies:NetIncome: -52206 USD (2007-03-01 to 2008-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001062993-09-002075.txt#3911 The citation records this snapshot. The page link may show a newer release later.	−USD 36,741 Exact value Exact value: -36741 USD 2007-03-01 – 2008-02-29: -36741 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TheraBiogen, Inc. · 2008-02-29 TheraBiogen, Inc. (edgar:1405286) Operating Cash Flow: -36741 USD Concept: fundies:OperatingCashFlow Period: 2007-03-01 to 2008-02-29 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3AOperatingCashFlow&period=2008-02-29&surface=latest&period_type=duration&start=2007-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36741 USD (2007-03-01 to 2008-02-29) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001062993-09-002075.txt#4074 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2008-03-01 – 2009-02-28	−USD 55,335 Exact value Exact value: -55335 USD 2008-03-01 – 2009-02-28: -55335 USD Inspect Net Income Open source Share or cite Citation for Net Income · TheraBiogen, Inc. · 2009-02-28 TheraBiogen, Inc. (edgar:1405286) Net Income: -55335 USD Concept: fundies:NetIncome Period: 2008-03-01 to 2009-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3ANetIncome&period=2009-02-28&surface=latest&period_type=duration&start=2008-03-01&unit=USD&dimensions= Input fundies:NetIncome: -55335 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001062993-09-002075.txt#3911 The citation records this snapshot. The page link may show a newer release later.	−USD 1,846 Exact value Exact value: -1846 USD 2008-03-01 – 2009-02-28: -1846 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TheraBiogen, Inc. · 2009-02-28 TheraBiogen, Inc. (edgar:1405286) Operating Cash Flow: -1846 USD Concept: fundies:OperatingCashFlow Period: 2008-03-01 to 2009-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3AOperatingCashFlow&period=2009-02-28&surface=latest&period_type=duration&start=2008-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1846 USD (2008-03-01 to 2009-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001062993-09-002075.txt#4074 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2009-03-01 – 2010-02-28	−USD 945,641 Exact value Exact value: -945641 USD 2009-03-01 – 2010-02-28: -945641 USD Inspect Net Income Open source Share or cite Citation for Net Income · TheraBiogen, Inc. · 2010-02-28 TheraBiogen, Inc. (edgar:1405286) Net Income: -945641 USD Concept: fundies:NetIncome Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3ANetIncome&period=2010-02-28&surface=latest&period_type=duration&start=2009-03-01&unit=USD&dimensions= Input fundies:NetIncome: -945641 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5033 The citation records this snapshot. The page link may show a newer release later.	−USD 597,734 Exact value Exact value: -597734 USD 2009-03-01 – 2010-02-28: -597734 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TheraBiogen, Inc. · 2010-02-28 TheraBiogen, Inc. (edgar:1405286) Operating Cash Flow: -597734 USD Concept: fundies:OperatingCashFlow Period: 2009-03-01 to 2010-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3AOperatingCashFlow&period=2010-02-28&surface=latest&period_type=duration&start=2009-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -597734 USD (2009-03-01 to 2010-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5185 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2011 2010-03-01 – 2011-02-28	−USD 4.09 million Exact value Exact value: -4093379 USD 2010-03-01 – 2011-02-28: -4093379 USD Inspect Net Income Open source Share or cite Citation for Net Income · TheraBiogen, Inc. · 2011-02-28 TheraBiogen, Inc. (edgar:1405286) Net Income: -4093379 USD Concept: fundies:NetIncome Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3ANetIncome&period=2011-02-28&surface=latest&period_type=duration&start=2010-03-01&unit=USD&dimensions= Input fundies:NetIncome: -4093379 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5033 The citation records this snapshot. The page link may show a newer release later.	−USD 1.33 million Exact value Exact value: -1331402 USD 2010-03-01 – 2011-02-28: -1331402 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · TheraBiogen, Inc. · 2011-02-28 TheraBiogen, Inc. (edgar:1405286) Operating Cash Flow: -1331402 USD Concept: fundies:OperatingCashFlow Period: 2010-03-01 to 2011-02-28 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/1405286/explain?concept=fundies%3AOperatingCashFlow&period=2011-02-28&surface=latest&period_type=duration&start=2010-03-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1331402 USD (2010-03-01 to 2011-02-28) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1405286/0001013762-11-001855.txt#5185 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

32 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001405286, 1405286, edgar:1405286

Also known as Kushi Resources Inc

TheraBiogen, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2011 2010-03-01 – 2011-02-28

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation